Neurosense Therapeutics Ltd
NRSN
查看详细走势图
0.940USD
+0.070+8.03%
收盘 02/06, 16:00（美东）报价延迟15分钟
23.12M总市值
亏损市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
+8.03%
5天
+2.16%
1月
+0.20%
6月
-25.40%
今年开始到现在
+22.22%
1年
-18.97%
查看详细走势图
TradingKey股票评分
由于缺少必要的数据，暂不能对该公司进行评分
Neurosense Therapeutics Ltd新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Neurosense Therapeutics Ltd简介
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
公司代码NRSN
公司Neurosense Therapeutics Ltd
CEOBen-Noon (Alon)
网址https://www.neurosense-tx.com/
相关品种
